GNAS and neoplasm: We amplified regions of 192 somatic mutations (including SNVs and INDELs) and the KRAS and GNAS hotspot mutations from DNAs extracted from the corresponding FFPE tumor samples and validated them by deep sequencing and capillary sequencer.